Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step

TOSHIAKI TANAKA, TAKASHI KOBUNAI, YOKO YAMAMOTO, SHIGENOBU EMOTO, KOJI MURONO, MANABU KANEKO, KAZUHITO SASAKI, KENSUKE OTANI, TAKESHI NISHIKAWA, KAZUSHIGE KAWAI, KEISUKE HATA, HIROAKI NOZAWA and TOSHIAKI WATANABE
Cancer Genomics & Proteomics September 2017, 14 (5) 341-348;
TOSHIAKI TANAKA
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: toshi-t{at}venus.dti.ne.jp
TAKASHI KOBUNAI
2Translational Research Laboratory, Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOKO YAMAMOTO
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGENOBU EMOTO
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI MURONO
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANABU KANEKO
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHITO SASAKI
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENSUKE OTANI
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI NISHIKAWA
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUSHIGE KAWAI
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEISUKE HATA
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROAKI NOZAWA
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIAKI WATANABE
1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 14 no. 5 341-348
PMID 
28871001

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received July 15, 2017
  • Revision received August 3, 2017
  • Accepted August 4, 2017
  • Published online September 4, 2017.

Copyright & License 
Copyright © 2017 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. TOSHIAKI TANAKA1,*⇑,
  2. TAKASHI KOBUNAI2,*,
  3. YOKO YAMAMOTO1,
  4. SHIGENOBU EMOTO1,
  5. KOJI MURONO1,
  6. MANABU KANEKO1,
  7. KAZUHITO SASAKI1,
  8. KENSUKE OTANI1,
  9. TAKESHI NISHIKAWA1,
  10. KAZUSHIGE KAWAI1,
  11. KEISUKE HATA1,
  12. HIROAKI NOZAWA1 and
  13. TOSHIAKI WATANABE1
  1. 1Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan
  2. 2Translational Research Laboratory, Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
  1. Correspondence to: Toshiaki Tanaka MD, Ph.D., Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan. E-mail: toshi-t{at}venus.dti.ne.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 9 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Cancer Genomics & Proteomics
Vol. 14, Issue 5
September-October 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step
TOSHIAKI TANAKA, TAKASHI KOBUNAI, YOKO YAMAMOTO, SHIGENOBU EMOTO, KOJI MURONO, MANABU KANEKO, KAZUHITO SASAKI, KENSUKE OTANI, TAKESHI NISHIKAWA, KAZUSHIGE KAWAI, KEISUKE HATA, HIROAKI NOZAWA, TOSHIAKI WATANABE
Cancer Genomics & Proteomics Sep 2017, 14 (5) 341-348;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step
TOSHIAKI TANAKA, TAKASHI KOBUNAI, YOKO YAMAMOTO, SHIGENOBU EMOTO, KOJI MURONO, MANABU KANEKO, KAZUHITO SASAKI, KENSUKE OTANI, TAKESHI NISHIKAWA, KAZUSHIGE KAWAI, KEISUKE HATA, HIROAKI NOZAWA, TOSHIAKI WATANABE
Cancer Genomics & Proteomics Sep 2017, 14 (5) 341-348;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer
  • Hypermethylation of Corticotropin Releasing Hormone Receptor-2 Gene in Ulcerative Colitis Associated Colorectal Cancer
  • Google Scholar

More in this TOC Section

  • Effects of Isthmus Topography on the Molecular Characteristics of BRAF-mutant Papillary Thyroid Cancer
  • Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines
  • Integrated Proteomics Reveal ALDH1A1 as an Oncogenic Driver and Regulatory Hub in Hepatocellular Carcinoma
Show more Experimental Studies

Keywords

  • Ulcerative colitis
  • carcinogenesis
  • CDH1
  • FGFR2
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire